Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming.
Saved in:
| Title: | Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming. |
|---|---|
| Authors: | Sanchez-Castro EE; Faculty of Biological Sciences, Universidad Nacional Mayor de San Marcos, Lima, Peru., Pajuelo-Reyes C; Institute of Tropical Diseases, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas, Chachapoyas, Peru., Tejedo R; Faculty of Medicine, Universidad Privada San Juan Bautista, Lima, Peru., Soria-Juan B; Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, Seville, Spain.; Department of Surgery, Fundación Jiménez Díaz, Unidad de Terapias Avanzadas, Universidad Autónoma de Madrid, Madrid, Spain., Tapia-Limonchi R; Institute of Tropical Diseases, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas, Chachapoyas, Peru., Andreu E; ISABIAL-Hospital General y Universitario de Alicante, Alicante, Spain.; Departmento de Fisica Aplicadas, University Miguel Hernández, Alicante, Spain., Hitos AB; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, University of Pablo de Olavide-University of Sevilla-CSIC, Seville, Spain.; Biomedical Research Network for Diabetes and Related Metabolic Diseases-CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain., Martin F; Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, Seville, Spain.; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, University of Pablo de Olavide-University of Sevilla-CSIC, Seville, Spain.; Biomedical Research Network for Diabetes and Related Metabolic Diseases-CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain., Cahuana GM; Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, Seville, Spain.; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, University of Pablo de Olavide-University of Sevilla-CSIC, Seville, Spain., Guerra-Duarte C; Center of Research and Development, Fundação Ezequiel Dias, Belo Horizonte, Brazil., de Assis TCS; Departament of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Bedoya FJ; Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, Seville, Spain.; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, University of Pablo de Olavide-University of Sevilla-CSIC, Seville, Spain.; Biomedical Research Network for Diabetes and Related Metabolic Diseases-CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain., Soria B; Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, Seville, Spain.; ISABIAL-Hospital General y Universitario de Alicante, Alicante, Spain.; Biomedical Research Network for Diabetes and Related Metabolic Diseases-CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain.; Institute of Bioengineering, University Miguel Hernandez de Elche, Alicante, Spain., Chávez-Olórtegui C; Departament of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Tejedo JR; Institute of Tropical Diseases, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas, Chachapoyas, Peru.; Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, Seville, Spain.; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, University of Pablo de Olavide-University of Sevilla-CSIC, Seville, Spain.; Biomedical Research Network for Diabetes and Related Metabolic Diseases-CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain. |
| Source: | Frontiers in immunology [Front Immunol] 2021 Feb 03; Vol. 11, pp. 609961. Date of Electronic Publication: 2021 Feb 03 (Print Publication: 2020). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2020.609961 |
